Axa S.A.
AXAHF | OTC
$46.25
+$0.55 (+1.20%)
Oct 28, 2025, 1:44 PM ET · Market open
Fiscal Year Period Ending | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 | FY 2019 Dec 30, 2019 |
|---|---|---|---|---|---|---|
Revenue | 89.82B | 87.15B | 86.79B | 111.69B | 112.35B | 124.94B |
Cost of Revenue | -1.9B | -1.77B | 12.71B | 12.67B | n/a | n/a |
Gross Profit | 89.82B | 87.15B | 86.79B | 99.03B | 112.35B | 124.94B |
Operating Income | 9.98B | 9.22B | 7.38B | 9.66B | 5.35B | 1.84B |
Interest Income | n/a | n/a | 248M | 472M | n/a | 720M |
Pretax Income | 9.98B | 8.89B | 6.58B | 9.2B | 4.87B | 5.62B |
Net Income | 7.89B | 7.19B | 5.06B | 7.29B | 3.16B | 3.86B |
Selling & General & Admin | n/a | n/a | 10.37B | 10.39B | 10.72B | 10.72B |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 79.85B | 77.93B | 51.8B | 102.27B | 96.28B | -133.82B |
Operating Expenses | 79.85B | 77.93B | 62.17B | 112.66B | 107B | -123.1B |
Interest Expense | 607M | 609M | 652M | 462M | 878M | 720M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 79.85B | 77.93B | 79.41B | 102.49B | 107B | 119.32B |
Income Tax Expense | 2.46B | 1.51B | 1.38B | 1.69B | 1.54B | 1.42B |
Shares Outstanding (Basic) | 2.19B | 2.28B | 2.29B | 2.38B | 2.38B | 2.38B |
Shares Outstanding (Diluted) | 2.2B | 2.26B | 2.3B | 2.39B | 2.39B | 2.39B |
EPS (Basic) | 3.51 | 3.05 | 2.13 | 2.98 | 1.25 | 1.51 |
EPS (Diluted) | 3.50 | 3.13 | 2.12 | 2.97 | 1.25 | 1.51 |
EBITDA | 10.59B | -738M | 7.29B | 10.05B | 2.84B | 3.22B |
EBIT | 10.59B | 9.05B | 7.24B | 9.66B | 5.75B | 8.18B |
Depreciation & Amortization | n/a | -9.96B | 54M | 388M | 1.18B | 1.38B |
Add to Watchlist
Select watchlists to add or remove AXAHF